events-conferences-en

Nojine Scientists Present Breakthrough Clinical Research at 25th International Congress of Pharmaceutical Biotechnology

Date: September 18, 2026 | Read Time: 4 mins
Nojine Scientists Present Breakthrough Clinical Research at 25th International Congress of Pharmaceutical Biotechnology
Presentation of three prominent research papers regarding efficacy optimization of Albojin in intensive care units received accolades from international scientific panels.

The scientific research and development delegation of Nojine Zist Pharmed actively participated in the 25th International Congress of Pharmaceutical Biotechnology, delivering three keynote technical papers on plasma therapeutics innovation.

The presented papers focused on optimizing colloid oncotic pressure restoration using Albujine in critical care and sepsis management, novel spectroscopic assays for detecting trace polymer aggregates, and enhanced downstream purification yielding higher protein monomer purity.

The symposium session was attended by renowned clinical pharmacologists, bioprocess engineers, and healthcare researchers, highlighting Nojine’s prominent scientific standing in regional biotechnology development.

Related Research Findings

Strategic Collaboration Agreement Signed Between Nojine Zist Pharmed and Pasteur Institute of Iran
strategic-partnerships-en

Strategic Collaboration Agreement Signed Between Nojine Zist Pharmed and Pasteur Institute of Iran

Read Time: 3 mins September 18, 2026
Nojine Achieves 100% Pharmacopoeial Compliance Under WHO-GMP Biological Standards
rnd-production-en

Nojine Achieves 100% Pharmacopoeial Compliance Under WHO-GMP Biological Standards

Read Time: 5 mins September 18, 2026
Nojine Upgrades Cold Chain Supply Infrastructure with Smart IoT and Cloud Telemetry Sensors
corporate-announcements-en

Nojine Upgrades Cold Chain Supply Infrastructure with Smart IoT and Cloud Telemetry Sensors

Read Time: 3 mins September 18, 2026